These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 25305410)

  • 1. Selective estrogen-receptor modulators suppress microglial activation and neuronal cell death via an estrogen receptor-dependent pathway.
    Ishihara Y; Itoh K; Ishida A; Yamazaki T
    J Steroid Biochem Mol Biol; 2015 Jan; 145():85-93. PubMed ID: 25305410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory effect of selective estrogen receptor modulators (SERMs) in microglial cells.
    Suuronen T; Nuutinen T; Huuskonen J; Ojala J; Thornell A; Salminen A
    Inflamm Res; 2005 May; 54(5):194-203. PubMed ID: 15953991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
    Kallio A; Guo T; Lamminen E; Seppänen J; Kangas L; Väänänen HK; Härkönen P
    Mol Cell Endocrinol; 2008 Jul; 289(1-2):38-48. PubMed ID: 18455292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective oestrogen receptor (ER) modulators reduce microglia reactivity in vivo after peripheral inflammation: potential role of microglial ERs.
    Tapia-Gonzalez S; Carrero P; Pernia O; Garcia-Segura LM; Diz-Chaves Y
    J Endocrinol; 2008 Jul; 198(1):219-30. PubMed ID: 18460549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen provides neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-alpha and estrogen receptor-beta in microglia.
    Liu X; Fan XL; Zhao Y; Luo GR; Li XP; Li R; Le WD
    J Neurosci Res; 2005 Sep; 81(5):653-65. PubMed ID: 16013043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the antiestrogens tamoxifen and raloxifene on the estrogen receptor transactivation machinery.
    Glaeser M; Niederacher D; Djahansouzi S; Hanstein B; Dittrich R; Beckmann MW; Fasching PA; Ackermann S
    Anticancer Res; 2006; 26(1B):735-44. PubMed ID: 16739346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line.
    Guzmán CB; Deighton-Collins S; Martinez A; Kleerekoper M; Zhao C; Benjamins JA; Skafar DF
    Neuro Endocrinol Lett; 2005 Oct; 26(5):526-32. PubMed ID: 16264406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple transcription factor elements collaborate with estrogen receptor alpha to activate an inducible estrogen response element in the NKG2E gene.
    Levy N; Zhao X; Tang H; Jaffe RB; Speed TP; Leitman DC
    Endocrinology; 2007 Jul; 148(7):3449-58. PubMed ID: 17395694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
    Dardes RC; Schafer JM; Pearce ST; Osipo C; Chen B; Jordan VC
    Gynecol Oncol; 2002 Jun; 85(3):498-506. PubMed ID: 12051881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.
    Ball LJ; Levy N; Zhao X; Griffin C; Tagliaferri M; Cohen I; Ricke WA; Speed TP; Firestone GL; Leitman DC
    Mol Cell Endocrinol; 2009 Feb; 299(2):204-11. PubMed ID: 19059307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Selective estrogen receptor modulators (SERMs)].
    Matsumoto T
    Clin Calcium; 2006 Sep; 16(9):1520-25. PubMed ID: 16951478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen mediated estrogen receptor activation protects against early impairment of hippocampal neuron excitability in an oxygen/glucose deprivation brain slice ischemia model.
    Zhang H; Xie M; Schools GP; Feustel PF; Wang W; Lei T; Kimelberg HK; Zhou M
    Brain Res; 2009 Jan; 1247():196-211. PubMed ID: 18992727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential actions of estrogen and SERMs in regulation of the actin cytoskeleton of endometrial cells.
    Flamini MI; Sanchez AM; Goglia L; Tosi V; Genazzani AR; Simoncini T
    Mol Hum Reprod; 2009 Oct; 15(10):675-85. PubMed ID: 19541800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain.
    Sumner BE; Grant KE; Rosie R; Hegele-Hartung Ch; Fritzemeier KH; Fink G
    Neurosci Lett; 2007 Apr; 417(1):95-9. PubMed ID: 17398000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta.
    Tee MK; Rogatsky I; Tzagarakis-Foster C; Cvoro A; An J; Christy RJ; Yamamoto KR; Leitman DC
    Mol Biol Cell; 2004 Mar; 15(3):1262-72. PubMed ID: 14699072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astrocyte-derived transforming growth factor-{beta} mediates the neuroprotective effects of 17{beta}-estradiol: involvement of nonclassical genomic signaling pathways.
    Dhandapani KM; Wade FM; Mahesh VB; Brann DW
    Endocrinology; 2005 Jun; 146(6):2749-59. PubMed ID: 15746252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin.
    Gielen SC; Burger CW; Kühne LC; Hanifi-Moghaddam P; Blok LJ
    J Soc Gynecol Investig; 2005 Oct; 12(7):e55-67. PubMed ID: 16202921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
    Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
    Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells.
    Lee TH; Chuang LY; Hung WC
    Oncogene; 2000 Aug; 19(33):3766-73. PubMed ID: 10949931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective oestrogen receptor modulators decrease the inflammatory response of glial cells.
    Arevalo MA; Diz-Chaves Y; Santos-Galindo M; Bellini MJ; Garcia-Segura LM
    J Neuroendocrinol; 2012 Jan; 24(1):183-90. PubMed ID: 21564348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.